Our Services
Medical Information
Helpful Resources
Published on: 8/18/2026
Hypophosphatasia-related craniosynostosis is managed through a staged, multidisciplinary plan, and several timing factors matter more than most parents expect, so see below for the full details. Key milestones typically include early diagnosis in infancy through low alkaline phosphatase testing and ALPL genetic confirmation, baseline imaging and skull growth tracking, then surgical release (endoscopic strip craniectomy with helmet therapy in young infants, or cranial vault remodeling and spring-assisted expansion in older or more complex cases) to relieve rising intracranial pressure. Because sutures often refuse after surgery in HPP, neurosurgeons plan for long-term surveillance of head circumference, eye exams for papilledema, and monitoring for Chiari malformation or hydrocephalus, with repeat procedures more common than in isolated craniosynostosis. Coordination with metabolic bone specialists on enzyme replacement therapy, plus developmental, ophthalmology, and dental follow-up through childhood, is part of the standard pathway, and the complete answer below explains what signs should prompt urgent re-evaluation. If your child has an unusual head shape, a bulging or prematurely closed soft spot
Hypophosphatasia (HPP) is a rare bone-mineral disorder that can speed up the fusion of an infant’s cranial sutures, leading to craniosynostosis. Pediatric neurosurgeons work closely with metabolic specialists, geneticists, and craniofacial teams to guide families through diagnosis, planning, surgery, and long-term follow-up. Understanding key milestones—including optimal premature suture fusion surgery timing—helps ensure the best outcomes for growth, development, and appearance.
What is HPP?
A genetic condition that impairs bone mineralization. Low alkaline phosphatase levels make bones softer and more brittle.
Why do sutures fuse early?
In HPP, abnormal bone turnover can cause one or more cranial sutures (the soft “gaps” between skull plates) to close too soon. This restricts normal skull growth and may increase intracranial pressure.
Signs to watch for:
Clinical exam
Imaging studies
Laboratory and genetic tests
Multidisciplinary review
Determining the right time for surgery is a balance between:
Key recommendation from pediatric neurosurgical guidelines:
“Plan definitive cranial vault remodeling once metabolic parameters are optimized, typically before 9 months of age, to harness skull flexibility and minimize revision rates.”
Pediatric neurosurgeons tailor the approach based on the child’s age, suture involvement, and overall health.
Endoscopic-assisted suturectomy
Open cranial vault remodeling
Combined approaches
Post-operative milestones:
Successful treatment extends beyond the operating room:
Metabolic management
Anesthesia considerations
Pain and comfort
Nutritional support
Ongoing care safeguards both neurological health and cosmetic outcomes:
Growth monitoring
Neurodevelopmental screening
Hearing and vision checks
Possible revision surgery
Even if your child has had surgery, it’s important to stay ahead of any new issues. Consider a free, online symptom check, using the doctor approved Ubie Symptom Checker to track any emerging concerns about head shape, development, or overall health.
Always reach out promptly if your child shows:
Speak to a doctor about anything that feels life-threatening, serious, or simply worrisome. Early communication and a strong care team partnership are key to helping your child thrive.
By understanding each milestone—from diagnosis and metabolic management through optimal premature suture fusion surgery timing, surgical techniques, and long-term follow-up—families can navigate HPP craniosynostosis with confidence. Pediatric neurosurgeons and craniofacial teams remain committed to personalized care, aiming for safe surgery, healthy development, and an improved quality of life.
(References)
* Mornet E. Hypophosphatasia. Orphanet J Rare Dis. 2007 Oct 4;2:40. doi: 10.1186/1750-1172-2-40. Epub 2007 Oct 4. PMID: 17916236; PMCID: PMC2164941.
* Beck C, Morbach H, Stenzel M, Schneider P, Collmann H, Girschick G, Girschick HJ. [Hypophosphatasia]. Klin Padiatr. 2009 Jul-Aug;221(4):219-26. doi: 10.1055/s-0029-1220718. Epub 2009 Jul 23. PMID: 19629901.
* Adam MP, Bick S, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, Dahir KM, Nunes ME. Hypophosphatasia. 1993. PMID: 20301329.
* Millán JL, Whyte MP. Alkaline Phosphatase and Hypophosphatasia. Calcif Tissue Int. 2016 Apr;98(4):398-416. doi: 10.1007/s00223-015-0079-1. Epub 2015 Nov 21. PMID: 26590809; PMCID: PMC4824800.
* Linglart A, Biosse-Duplan M. Hypophosphatasia. Curr Osteoporos Rep. 2016 Jun;14(3):95-105. doi: 10.1007/s11914-016-0309-0. PMID: 27084188.
* Di Rocco F, Baujat G, Cormier-Daire V, Rothenbuhler A, Linglart A. Craniosynostosis and hypophosphatasia. Arch Pediatr. 2017 May;24(5S2):5S89-5S92. doi: 10.1016/S0929-693X(18)30022-8. PMID: 29405940.
* Whyte MP, Simmons JH, Moseley S, Fujita KP, Bishop N, Salman NJ, Taylor J, Phillips D, McGinn M, McAlister WH. Asfotase alfa for infants and young children with hypophosphatasia: 7 year outcomes of a single-arm, open-label, phase 2 extension trial. Lancet Diabetes Endocrinol. 2019 Feb;7(2):93-105. doi: 10.1016/S2213-8587(18)30307-3. Epub 2018 Dec 14. PMID: 30558909.
* Di Rocco F, Rothenbuhler A, Cormier Daire V, Bacchetta J, Adamsbaum C, Baujat G, Rossi M, Lingart A. Craniosynostosis and metabolic bone disorder. A review. Neurochirurgie. 2019 Nov;65(5):258-263. doi: 10.1016/j.neuchi.2019.09.008. Epub 2019 Sep 25. PMID: 31562881.
* Dahir KM, Shannon A, Dunn D, Voegtli W, Dong Q, Hasan J, Pradhan R, Pelto R, Pan WJ. Safety, pharmacokinetics, and pharmacodynamics of efzimfotase alfa, a second-generation enzyme replacement therapy: phase 1, dose-escalation study in adults with hypophosphatasia. J Bone Miner Res. 2024 Sep 26;39(10):1412-1423. doi: 10.1093/jbmr/zjae128. PMID: 39135540; PMCID: PMC11425692.
* Seefried L, Genest F, Hofmann C, Brandi ML, Rush E. Diagnosis and Treatment of Hypophosphatasia. Calcif Tissue Int. 2025 Mar 6;116(1):46. doi: 10.1007/s00223-025-01356-y. Epub 2025 Mar 6. PMID: 40047955; PMCID: PMC11885340.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.